Stem cells in alzheimer’s disease: Current standing and future challenges

6Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.
Get full text

Abstract

To date, there is no definitive treatment for Alzheimer’s disease (AD). The realm of stem cells is very promising in regenerative medicine, particularly for neurodegenerative diseases. Various types of stem cells have been used in preclinical/clinical trials for AD aiming the development of an elusive disease modifying therapy. Over the last decade, much knowledge has been gained in this field regarding types of cells, routes and timing of administration, and outcomes of stem cells-based strategies for AD. In this chapter, we will trace the state of art and the challenges facing the use of stem cells in AD.

Cite

CITATION STYLE

APA

Salem, H., Colpo, G. D., & Teixeira, A. L. (2018). Stem cells in alzheimer’s disease: Current standing and future challenges. In Advances in Experimental Medicine and Biology (Vol. 1079, pp. 93–102). Springer New York LLC. https://doi.org/10.1007/5584_2018_214

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free